NNNN - CIK 0001982708
Anbio Biotechnology (NNNN) reported revenue of $8.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $8.65M | +5.6% |
| FY 2024 | $8.19M | +21.9% |
| FY 2023 | $6.71M | -71.5% |
| FY 2022 | $23.54M | - |
Anbio Biotechnology (NNNN) reported revenue of $8.65M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.